American Journal of Cardiology
Volume 108, Issue 2 , Pages 294-301 , 15 July 2011

Meta-Analysis of Randomized Controlled Trials on Effect of Angiotensin-Converting Enzyme Inhibitors on Cancer Risk

  • Ilke Sipahi, MD

      Affiliations

    • Harrington-McLaughlin Heart and Vascular Institute, University Hospitals Case Medical Center, Case Western Reserve University School of Medicine, Cleveland, Ohio
    • Corresponding Author InformationCorresponding author: Tel: 216-844-1639; fax: 216-844-8954
    • ,
  • Josephine Chou, MD

      Affiliations

    • Harrington-McLaughlin Heart and Vascular Institute, University Hospitals Case Medical Center, Case Western Reserve University School of Medicine, Cleveland, Ohio
    • ,
  • Prasun Mishra, MD

      Affiliations

    • Harrington-McLaughlin Heart and Vascular Institute, University Hospitals Case Medical Center, Case Western Reserve University School of Medicine, Cleveland, Ohio
    • ,
  • Sara M. Debanne, PhD

      Affiliations

    • Department of Epidemiology and Biostatistics, Case Western Reserve University School of Medicine, Cleveland, Ohio
    • ,
  • Daniel I. Simon, MD

      Affiliations

    • Harrington-McLaughlin Heart and Vascular Institute, University Hospitals Case Medical Center, Case Western Reserve University School of Medicine, Cleveland, Ohio
    • ,
  • James C. Fang, MD

      Affiliations

    • Harrington-McLaughlin Heart and Vascular Institute, University Hospitals Case Medical Center, Case Western Reserve University School of Medicine, Cleveland, Ohio

Received 31 January 2011 ,Revised 11 March 2011 ,Accepted 11 March 2011.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Dr. Sipahi received an educational grant (2004) and lecture honoraria from Pfizer (once, 2007), and lecture honoraria from AstraZeneca (once, 2008) and Ranbaxy (once, 2010). Dr. Debanne is a member of the data monitoring committee for Centocor Research & Development, Inc. Dr. Simon serves on advisory boards for Cordis/Johnson & Johnson, Daiichi-Sankyo, Medicines Company, Medtronic Vascular, Portola, and Schering-Plough, and has received lecture honoraria from Accumetrics, Cordis/Johnson & Johnson, Daiichi-Sankyo, Eli Lilly, Medicines Company, Sanofi-Aventis, and Schering-Plough. Dr. Fang serves on an advisory panel for Novartis and as a consultant for ARCA Biopharma, Inc.

PII: S0002-9149(11)01279-3

doi: 10.1016/j.amjcard.2011.03.038

American Journal of Cardiology
Volume 108, Issue 2 , Pages 294-301 , 15 July 2011

Article Tools

* Image Usage & Resolution